Literature DB >> 11494557

[Current status of tissue engineering for therapeutic use].

T Shinoka1, Y Imai, G Matsumura.   

Abstract

During the past three decades, significant advances have been made in the field of transplantation. However, clinical obstacles such as donor scarcity, cost, infection and life-long immunosuppression(especially within the pediatric age group) have become the major limitations for organ transplantation. This article discusses the recent progresses as well as the remaining challenges in tissue engineering that may enable such technology to replace organ transplantation. Additionally, we describe a practical method for tissue engineering in the field of cardiovascular surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494557

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  1 in total

Review 1.  Concise review: tissue-engineered vascular grafts for cardiac surgery: past, present, and future.

Authors:  Hirotsugu Kurobe; Mark W Maxfield; Christopher K Breuer; Toshiharu Shinoka
Journal:  Stem Cells Transl Med       Date:  2012-06-28       Impact factor: 6.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.